New data from a landmark meta-analysis of 40 prospective cohort studies presents compelling statistics on magnesium’s selective cardiovascular benefits. For every 100 milligrams of additional daily magnesium intake, the research documents a 22% reduction in heart failure risk, a 7% reduction in stroke risk, and a 19% reduction in type 2 diabetes risk across more than one million study participants.
However, these benefits come with an important caveat: magnesium shows no protective effect against overall cardiovascular disease or coronary heart disease. This distinction is critical for patients and healthcare providers, as supplement marketing often implies broader cardiovascular protection than the evidence supports. The study underscores the importance of understanding which specific health outcomes benefit from nutritional intervention, ensuring that dietary and supplementation strategies are evidence-informed rather than based on promotional claims.
Was this article helpful?
GMJ Brief · Key Finding
📰 Read the full article: Magnesium and Heart Disease: What the Evidence Actually Shows →
